MedPath
TGA Approval

MADOPAR 62.5 levodopa 50 mg and benserazide 12.5 mg capsule bottle (13744)

13744

MADOPAR 62.5 levodopa 50 mg and benserazide 12.5 mg capsule bottle

Roche Products Pty Ltd

August 23, 1991

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-CMI-01768-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-02391-3

Active Ingredients

benserazide hydrochloride

levodopa

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.